Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ayala Pharmaceuticals, Inc. (AYLA)

1.38   -0.03 (-2.13%) 08-19 02:11
Open: 1.42 Pre. Close: 1.41
High: 1.42 Low: 1.29
Volume: 211,266 Market Cap: 20(M)
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.42 - 1.43 1.43 - 1.44
Low: 1.34 - 1.35 1.35 - 1.36
Close: 1.4 - 1.41 1.41 - 1.42

Technical analysis

as of: 2022-08-18 3:51:00 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.05     One year: 2.82
Support: Support1: 0.69    Support2: 0.58
Resistance: Resistance1: 1.76    Resistance2: 2.42
Pivot: 1.51
Moving Average: MA(5): 1.34     MA(20): 1.45
MA(100): 1.93     MA(250): 5.81
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 20.6     %D(3): 19.4
RSI: RSI(14): 49.2
52-week: High: 14.94  Low: 0.69
Average Vol(K): 3-Month: 2,402 (K)  10-Days: 239 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ AYLA ] has closed above bottom band by 28.8%. Bollinger Bands are 24.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 19 Aug 2022
Analysts Set Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) Price Target at $15.33 - Defense World

Tue, 16 Aug 2022
Stock Alert: Ayala (AYLA) Falling 10.40% in Pre-Market Hours for August 16 - Equities News

Sat, 13 Aug 2022
Meet Ayla's Cafe: Adelaide's hidden Persian gem • Glam Adelaide - Glam Adelaide

Fri, 12 Aug 2022
Ayla Busch was Honored with the German Leadership Award 2022 | impeller.net - The Online Pump Magazine - Impeller.net

Thu, 11 Aug 2022
Daihatsu exhibits Rocky hybrid model, AYLA BEV concept car and other vehicles at Gaikindo Indonesia International Auto Show 2022 - Automotive World

Mon, 08 Aug 2022
Where to Watch and Stream Ayla: The Daughter of War Free Online - EpicStream

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 14 (M)
% Held by Insiders 7.47e+006 (%)
% Held by Institutions 31.2 (%)
Shares Short 45 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -3.981e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 332.5
Return on Equity (ttm) -55.5
Qtrly Rev. Growth 2.99e+006
Gross Profit (p.s.) -22.37
Sales Per Share -44.14
EBITDA (p.s.) 0
Qtrly Earnings Growth -2.8
Operating Cash Flow 0 (M)
Levered Free Cash Flow -39 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.04
Price to Cash Flow 1.82

Stock Dividends

Dividend 0
Forward Dividend 30270
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.